Skip to main content
PMC home page
Cancer Science logoLink to Cancer Science
. 2005 Aug 19;95(3):211–217. doi: 10.1111/j.1349-7006.2004.tb02205.x

Unique characteristics of rectal carcinoma cell lines derived from invasive carcinomas in ulcerative colitis patients

Kazuya Yamashita 1,2, Shuichi Yasuda 3, Tatsuru Kuba 1,2, Yoshimasa Otani 4, Mutsunori Fujiwara 5, Isao Okayasu 1,2,✉
PMCID: PMC11159061  PMID: 15016319

Abstract

To identify the characteristics of ulcerative colitis (UC)‐associated carcinomas, 8 lesions, high‐grade dysplasias and invasive carcinomas, were implanted into severely combined immunodeficient (SCID) mice and/or cultured in vitro. Intramucosal neoplasias consisting of high‐grade dysplasia showed extremely slow proliferation after implantation (2/3 cases) and in vitro culture failed (4 cases). However, invasive carcinomas demonstrated rapid growth both after SCID mouse implantation and in vitro (4/4 cases). From two cases of invasive carcinomas, 6 cell lines were established, and these are the first to be described in the literature. In addition to variation in immunohistochemically determined phenotypic expression regarding α‐fetoprotein, chromogranin A and estrogen receptors, the established cell lines showed varying differentiation (moderately or poorly differentiated adenocarcinoma, adenosquamous carcinoma and poorly differentiated adenocarcinoma with multinuclear giant cells and bone formation). The results are in contrast with findings for sporadic colorectal carcinomas. Although the prevalence of DNA alterations is not frequent, loss of heterozygosity (17p and 18q) and deletion of exons 8 to 11 in DPC‐4 were revealed in all of 6 cell lines, suggesting relatively high genetic instability. We found loss or translocation of many chromosomes (#3, 5, 6, 8, 10, 11, 13, 16, 17, 18 and 19) other than chromosomes 1, 5, 8, 11, 13, 17 and 18, which are frequently involved in sporadic colorectal carcinoma cell lines. Thus, the established cell lines may be good models of tumorigenesis and progression in the chronic inflammation‐carcinoma sequence.

References

  • 1. Blackstone MO, Riddell RH, Rogers BH, Levin B. Dysplasia–associated lesion or mass (DALM) detected by colonoscopy in long–standing ulcerative colitis: an indication for colectomy. Gastroenterology 1981; 80: 366–74. [PubMed] [Google Scholar]
  • 2. Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, Ahren C, Correa P, Hamilton SR, Morson BC, Sommers SC, Yardley JH. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983; 11: 931–68. [DOI] [PubMed] [Google Scholar]
  • 3. Lennard‐Jones JE, Melville DM, Morson BC, Ritchie JK, Williams CB. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 1990; 31: 800–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Okayasu I, Fujiwara M, Takemura T, Toyoshima H, Nakamura K. Development of colorectal cancer in ulcerative colitis: clinicopathological study of 347 patients and new concepts of cancer. Stomach and Intestine (Tokyo) 1993; 28: 171–9. [Google Scholar]
  • 5. Okayasu I, Hana K, Yoshida T, Mikami T, Kanno J, Fujiwara M. Significant increase of colonic mutated crypts in ulcerative colitis correlatively with duration of illness. Cancer Res 2002; 62: 2236–8. [PubMed] [Google Scholar]
  • 6. Cook MG, Goligher JC. Carcinoma and epithelial dysplasia complicating ulcerative colitis. Gastroenterology 1975; 68: 1127–36. [PubMed] [Google Scholar]
  • 7. Greenwald BD, Harpaz N, Yin J, Huang Y, Tong Y, Brown VL, McDaniel T, Newkirk C, Resau JH, Meltzer SJ. Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis. Cancer Res 1992; 52: 741–5. [PubMed] [Google Scholar]
  • 8. Fogt F, Vortmeyer AO, Goldman H, Giordano TJ, Merino MJ, Zhuang Z. Comparison of genetic alterations in colonic adenoma and ulcerative colitis‐associated dysplasia and carcinoma. Hum Pathol 1998; 29: 131–6. [DOI] [PubMed] [Google Scholar]
  • 9. Rabinovitch PS, Dziadon S, Brentnall TA, Emond MJ, Crispin DA, Haggitt RC, Bronner MP. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. Cancer Res 1999; 59: 5148–53. [PubMed] [Google Scholar]
  • 10. Yoshida T, Mikami T, Mitomi H, Okayasu I. Diverse p53 alterations in ulcerative colitis‐associated low‐grade dysplasia: full‐length gene sequencing in microdissected single crypts. J Pathol 2003; 199: 166–75. [DOI] [PubMed] [Google Scholar]
  • 11. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning, a laboratory manual. 2nd ed. New York : Cold Spring Harbor Laboratory Press; 1987. [Google Scholar]
  • 12. Yamashita K, Yoshida T, Shinoda H, Okayasu I. Novel method for simultaneous analysis of p53 and K‐ras mutations and p53 protein expression in single histologic sections. Arch Pathol Lab Med 2001; 125: 347–52. [DOI] [PubMed] [Google Scholar]
  • 13. Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC, Perucho M. Somatic frameshift mutations in the BAX gene in colon cancers of the mic‐rosatellite mutator phenotype. Science 1997; 275: 967–9. [DOI] [PubMed] [Google Scholar]
  • 14. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M, Willson J. Inactivation of the type II TGF‐B receptor in colon cancer cells with microsatellite instability. Science 1995; 268: 1336–8. [DOI] [PubMed] [Google Scholar]
  • 15. Thiagalingam S, Lengauer C, Leach FS, Schutte M, Hahn SA, Overhauser J, Willson JK, Markowitz S, Hamilton SR, Kern SE, Kinzler KW, Vogelstein B. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 1996; 13: 343–6. [DOI] [PubMed] [Google Scholar]
  • 16. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez‐Bigas MA, Fodde R, Ranzani GN, Srivastava S. A National Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58: 5248–57. [PubMed] [Google Scholar]
  • 17. Fregeau CJ, Fourney RM. DNA typing with fluorescently tagged short tandem repeats: a sensitive and accurate approach to human identification. Biotechniques 1993; 15: 100–19. [PubMed] [Google Scholar]
  • 18. Miura I, Siegfried JM, Resau J, Keller SM, Zhou JY, Testa JR. Chromosome alterations in 21 non‐small cell lung carcinomas. Genes Chromosom Cancer 1990; 2: 328–38. [DOI] [PubMed] [Google Scholar]
  • 19. Hamden DG, Klinger HP. ISCN, an International System for Human Cytogenetic Nomenclature. Basel : S. Karger Co; 1985. [Google Scholar]
  • 20. Zalatnai A, Dubecz S, Harka I, Banhidy F Jr. Malignant teratoma of the left colon associated with chronic ulcerative colitis. Virchows Arch A Pathol Anat Histopathol 1987; 411: 61–5. [DOI] [PubMed] [Google Scholar]
  • 21. Miller RR, Sumner HW. Argyrophilic cell hyperplasia and an atypical carcinoid tumor in chronic ulcerative colitis. Cancer 1982; 50: 2920–5. [DOI] [PubMed] [Google Scholar]
  • 22. Lattes C, Carella R, Faggioli S, Gabusi E, Grigioni WF. Hepatoid adenocar‐cinoma of the rectum arising in ulcerative colitis: report of a case. Dis Colon Rectum 2000; 43: 105–8. [DOI] [PubMed] [Google Scholar]
  • 23. Tsushimi T, Noshima S, Oga A, Esato K, Sasaki K. DNA amplification and chromosomal translocations are accompanied by chromosomal instability: analysis of seven human colon cancer cell lines by comparative genomic hybridization and special karyotyping. Cancer Genet Cytogenet 2001; 126: 34–8. [DOI] [PubMed] [Google Scholar]
  • 24. Melcher R, Koehler S, Steinlein C, Schmid M, Mueller CR, Luehrs H, Scheppach TM, Moerk H, Scheurlen M, Koehrle J, Al‐Taie O. Spectral karyotype analysis of colon cancer cell lines of the tumor suppressor and mutator pathway. Cytogenet Genome Res 2002; 98: 22–8. [DOI] [PubMed] [Google Scholar]
  • 25. Bell SM, Kelly SA, Hoyle JA, Lewis FA, Taylor GR, Thompson H, Dixon MF, Quirke P. c‐Ki‐ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis. Br J Cancer 1991; 64: 174–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Burmer GC, Levine DS, Kulander BG, Haggitt RC, Rubin CE, Rabinovitch PS. c‐Ki‐ras mutations in chronic ulcerative colitis and sporadic colon carcinoma. Gastroentelogy 1990; 99: 416–20. [DOI] [PubMed] [Google Scholar]
  • 27. Chen J, Compton C, Cheng E, Fromowitz F, Viola MV. c‐Ki‐ras mutations in dysplastic fields and cancers in ulcerative colitis. Gastroenterology 1992; 102: 1983–7. [DOI] [PubMed] [Google Scholar]
  • 28. Chiao PJ, Hunt KK, Grau AM, Abramian A, Fleming J, Zhang W, Breslin T, Abbruzzese JL, Evans DB. Tumor suppressor gene Smad4/DPC4, its downstream target gene, and regulation of cell cycle. Ann N Y AcadSci 1999; 880: 31–7. [DOI] [PubMed] [Google Scholar]
  • 29. Holzmann K, Klump B, Borchard F, Hsieh CJ, Kuhn A, Gaco V, Gregor M, Porschen R. Comparative analysis of histology, DNA content, p53 and Ki‐ras mutations in colectomy specimens with long‐standing ulcerative colitis. Int J Cancer 1998; 76: 1–6. [DOI] [PubMed] [Google Scholar]
  • 30. Hussain SP, Amstad P, Raja K, Ambs S, Nagashima M, Bennett WP, Shields PG, Ham AJ, Swenberg JA, Marrogi AJ, Harris CC. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer‐prone chronic inflammatory disease. Cancer Res 2000; 60: 3333–7. [PubMed] [Google Scholar]
  • 31. Hoque AT, Hahn SA, Schutte M, Kern SE. DPC4 gene mutation in colitis‐associated neoplasia. Gut 1997; 40: 120–2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Tarmin L, Yin J, Harpaz N, Kozam M, Noordzij J, Antonio LB, Jiang HY, Chan O, Cymes K, Meltzer SJ. Adenomatous polyposis coli gene mutations in ulcerative colitis‐associated dysplasias and cancers versus sporadic colon neoplasms. Cancer Res 1995; 55: 2035–8. [PubMed] [Google Scholar]
  • 33. Aust DE, Terdiman JP, Willenbucher RF, Chang CG, Molinaro‐Clark A, Baretton GB, Loehrs U, Waldman FM. The APC/beta‐catenin pathway in ulcerative colitis‐related colorectal carcinomas: a mutational analysis. Cancer 2002; 94: 1421–7. [DOI] [PubMed] [Google Scholar]
  • 34. Burmer GC, Rabinovitch PS, Haggitt RC, Crispin DA, Brentnall TA, Kolli VR, Stevens AC, Rubin CE. Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele. Gastroenterology 1992; 103: 1602–10. [DOI] [PubMed] [Google Scholar]
  • 35. Odze RD, Brown CA, Hartmann CJ, Noffsinger AE, Fogt E Genetic alterations in chronic ulcerative colitis‐associated adenoma‐like DALMs are similar to non‐colitic sporadic adenomas. Am J Surg Pathol 2000; 24: 1209–16. [DOI] [PubMed] [Google Scholar]
  • 36. Grady WM, Myeroff LL, Swinler SE, Rajput A, Thiagalingam S, Lutterbaugh JD, Neumann A, Brattain MG, Chang J, Kim SJ, Kinzler KW, Vogelstein B, Willson JK, Markowitz S. Mutational inactivation of transforming growth factor receptor type II in microsatellite stable colon cancers. Cancer Res 1999; 59: 320–4. [PubMed] [Google Scholar]
  • 37. Matsumoto N, Yoshida T, Okayasu I. High epithelial and stromal genetic instability of chromosome 17 in ulcerative colitis‐associated carcinogenesis. Cancer Res 2003; 63: 6158–61. [PubMed] [Google Scholar]
  • 38. Matsushita M, Matsuzaki K, Date M, Watanabe T, Shibano K, Nakagawa T, Yanagitani S, Amoh Y, Takemoto H, Ogata N, Yamamoto C, Kubota Y, Seki T, Inokuchi H, Nishizawa M, Takada H, Sawamura T, Okamura A, Inoue K. Down‐regulation of TGF‐beta receptors in human colorectal cancer: implications for cancer development. Br J Cancer 1999; 80: 194–205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Miyaki M, Iijima T, Konishi M, Sakai K, Ishii A, Yasuno M, Hishima T, Koike M, Shitara N, Iwama T, Utsunomiya J, Kuroki T, Mori T. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene 1999; 18: 3098–103. [DOI] [PubMed] [Google Scholar]

Articles from Cancer Science are provided here courtesy of Wiley

RESOURCES